THE ARCH

Where Web3 founders, talent, and partners meet.

Daily Digest · Free
PLATFORM
  • Partners Directory
  • All Categories
  • Marketplace
  • Find a Partner
  • Docs
  • Escrow
INTELLIGENCE
  • Web3 News
  • Daily Digests
  • Intel Reports
  • Web3 Events
  • RSS Feed
  • Substack ↗
GET INVOLVED
  • Get Listed
  • Get Your Verified Badge
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Book a Call
COMPANY
  • About
  • How It Works
  • Manifesto
  • Media Kit
  • Privacy
  • Terms
© 2026 THE ARCH · All rights reserved.
PRIVACYTERMSCOOKIES
THE ARCH
THE ARCH

Where Web3 founders, talent, and partners meet.

Daily Digest · Free
PLATFORM
  • Partners Directory
  • All Categories
  • Marketplace
  • Find a Partner
  • Docs
  • Escrow
INTELLIGENCE
  • Web3 News
  • Daily Digests
  • Intel Reports
  • Web3 Events
  • RSS Feed
  • Substack ↗
GET INVOLVED
  • Get Listed
  • Get Your Verified Badge
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Book a Call
COMPANY
  • About
  • How It Works
  • Manifesto
  • Media Kit
  • Privacy
  • Terms
© 2026 THE ARCH · All rights reserved.
PRIVACYTERMSCOOKIES
THE ARCH
THE ARCH
Offers
POST A BRIEFJOIN AS PARTNER
News
Novo Nordisk Wegovy Pill Launches, Expanding Acces...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Arch TakeNeutral
AltcoinsRegulationTrading

Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Polygon CEO announces job cuts amid Coinme acquisition

Cointelegraph•5h ago

Leaks Reveal Suno Fed Thousands of Hours of Deezer, YouTube and Pond5 Data Into Its AI

Decrypt •6h ago

Trump teleprompter operator made $100K betting on Kalshi markets tied to speeches: ABC

Cointelegraph•6h ago

Australia's 50% Crypto CGT Discount Ends July 2027 - Forbes

Apify/Forbes•6h ago
← Back to News Feed
THE ARCH
Offers
POST A BRIEFJOIN AS PARTNER
News
Novo Nordisk Wegovy Pill Launches, Expanding Acces...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Arch TakeNeutral
AltcoinsRegulationTrading

Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Polygon CEO announces job cuts amid Coinme acquisition

Cointelegraph•5h ago

Leaks Reveal Suno Fed Thousands of Hours of Deezer, YouTube and Pond5 Data Into Its AI

Decrypt •6h ago

Trump teleprompter operator made $100K betting on Kalshi markets tied to speeches: ABC

Cointelegraph•6h ago

Australia's 50% Crypto CGT Discount Ends July 2027 - Forbes

Apify/Forbes•6h ago
← Back to News Feed